Sander Kelderman

4.4k total citations · 1 hit paper
12 papers, 2.0k citations indexed

About

Sander Kelderman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sander Kelderman has authored 12 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Sander Kelderman's work include CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (8 papers). Sander Kelderman is often cited by papers focused on CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (8 papers). Sander Kelderman collaborates with scholars based in Netherlands, Denmark and Switzerland. Sander Kelderman's co-authors include Ton N. Schumacher, John B.A.G. Haanen, Nienke van Rooij, Pia Kvistborg, Lorenzo F. Fanchi, Krijn K. Dijkstra, Emile E. Voest, Carsten Linnemann, Mireille Toebes and Marit M. van Buuren and has published in prestigious journals such as Science, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Sander Kelderman

12 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

2018 373 citations Wouter Scheper, Sander Kelderman et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sander Kelderman Netherlands	10	1.4k	1.2k	526	295	169	12	2.0k
Iñaki Etxeberría Spain	17	1.1k 0.7×	1.1k 1.0×	616 1.2×	222 0.8×	166 1.0×	25	1.9k
Arantza Azpilikueta Spain	26	1.6k 1.1×	1.8k 1.5×	438 0.8×	127 0.4×	180 1.1×	47	2.4k
Cristina Puig-Saus United States	13	1.4k 1.0×	1.0k 0.8×	704 1.3×	161 0.5×	238 1.4×	18	2.0k
Robin Parihar United States	22	1.4k 1.0×	1.5k 1.3×	482 0.9×	197 0.7×	197 1.2×	47	2.3k
Maite Álvarez United States	25	1.0k 0.7×	1.5k 1.2×	357 0.7×	173 0.6×	181 1.1×	67	2.1k
Willemijn Hobo Netherlands	26	1.3k 0.9×	1.5k 1.2×	520 1.0×	132 0.4×	79 0.5×	50	2.2k
Mathias Vormehr Germany	13	990 0.7×	1.2k 1.0×	850 1.6×	153 0.5×	166 1.0×	23	1.8k
Barbara Schrörs Germany	12	1.0k 0.7×	1.2k 1.0×	783 1.5×	163 0.6×	102 0.6×	23	1.7k
Christel Devaud Australia	16	1.4k 1.0×	1.0k 0.8×	441 0.8×	292 1.0×	322 1.9×	27	1.9k
Todd D. Armstrong United States	29	2.0k 1.4×	2.3k 1.9×	843 1.6×	190 0.6×	136 0.8×	54	3.3k

Countries citing papers authored by Sander Kelderman

Since Specialization

Citations

This map shows the geographic impact of Sander Kelderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander Kelderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander Kelderman more than expected).

Fields of papers citing papers by Sander Kelderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander Kelderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander Kelderman. The network helps show where Sander Kelderman may publish in the future.

Co-authorship network of co-authors of Sander Kelderman

This figure shows the co-authorship network connecting the top 25 collaborators of Sander Kelderman. A scholar is included among the top collaborators of Sander Kelderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander Kelderman. Sander Kelderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Cattaneo, Chiara, Krijn K. Dijkstra, Lorenzo F. Fanchi, et al.. (2019). Tumor organoid–T-cell coculture systems. Nature Protocols. 15(1). 15–39. 250 indexed citations

2.

Scheper, Wouter, Sander Kelderman, Lorenzo F. Fanchi, et al.. (2018). Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nature Medicine. 25(1). 89–94. 373 indexed citations breakdown →

3.

Strønen, Erlend, Mireille Toebes, Sander Kelderman, et al.. (2016). Targeting of cancer neoantigens with donor-derived T cell receptor repertoires. Science. 352(6291). 1337–1341. 323 indexed citations

4.

Kelderman, Sander, Bianca Heemskerk, Lorenzo F. Fanchi, et al.. (2016). Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapy. European Journal of Immunology. 46(6). 1351–1360. 31 indexed citations

5.

Kelderman, Sander, Ton N. Schumacher, & Pia Kvistborg. (2015). Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy. Cancer Cell. 28(1). 11–13. 64 indexed citations

6.

Kelderman, Sander & Pia Kvistborg. (2015). Tumor antigens in human cancer control. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1865(1). 83–89. 20 indexed citations

7.

Kvistborg, Pia, Daisy Philips, Sander Kelderman, et al.. (2014). Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response. Science Translational Medicine. 6(254). 254ra128–254ra128. 288 indexed citations

8.

Becattini, Simone, Daniela Latorre, Federico Mele, et al.. (2014). Functional heterogeneity of human memory CD4 ⁺ T cell clones primed by pathogens or vaccines. Science. 347(6220). 400–406. 239 indexed citations

9.

Kelderman, Sander, Ton N. Schumacher, & John B.A.G. Haanen. (2014). Acquired and intrinsic resistance in cancer immunotherapy. Molecular Oncology. 8(6). 1132–1139. 145 indexed citations

10.

Blank, Christian U., Sander Kelderman, Harm van Tinteren, et al.. (2013). Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma.. Journal of Clinical Oncology. 31(15_suppl). 3036–3036. 2 indexed citations

11.

Kelderman, Sander, Bianca Heemskerk, Mireille Toebes, et al.. (2013). Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations

12.

Urbańska, Katarzyna, Evripidis Lanitis, Mathilde Poussin, et al.. (2012). A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor. Cancer Research. 72(7). 1844–1852. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact